Hereby, BCL2A1 overexpression is described to be even more frequent than BCL-2 overexpression and seems to be predominantly in transformed, secondary AML or in the subset of M4/M5 according to FAB (French-American-British) classification. This evidence concerns the gene BCL2 and acute myeloid leukemia.